524804:BOM
Aurobindo Pharma Ltd
₹1.658,65
arrow_downward
-0,98%(-16,35) 1D
16 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 524804...
Open
₹1.683,55
High
₹1.683,55
Low
₹1.654,75
Mkt. cap
959,10 ຕື້
Avg. vol.
29,66 ພັນ
Volume
11,19 ພັນ
P/E ratio
25,92
52-wk high
₹1.739,95
52-wk low
₹1.080,10
EPS
₹64,00
Shares outstanding
585,90 ລ້ານ
No. of employees
29 ພັນ
Open
₹1.683,55
High
₹1.683,55
Low
₹1.654,75
Mkt. cap
959,10 ຕື້
Avg. vol.
29,66 ພັນ
Volume
11,19 ພັນ
P/E ratio
25,92
52-wk high
₹1.739,95
52-wk low
₹1.080,10
EPS
₹64,00
Shares outstanding
585,90 ລ້ານ
No. of employees
29 ພັນ
News stories
From web sources and news partners
Moneycontrol.com
·
2 ມື້ກ່ອນ
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees29,2 ພັນ
Founded1986
HeadquartersHyderabad, ອັນດຣາປະເທດ, ອິນເດຍ
SectorPharmaceutical industry
Websiteaurobindo.com